Something weird might be happening with Nvidia’s next-gen GPUs, because if the rumor mill is to be believed, we’re going to get a whole bunch of Blackwell GeForce graphics cards in the near ...
Nvidia stock has much more room to run up its all-time high share price set this week, argue Bank of America analysts, who just meaningfully upped their price target for the artificial ...
More competition pressures Nvidia’s pricing, margins and market share. Nvidia Corp.’s earnings results felt like a national holiday of sorts. Countdowns and endless commentary surrounded the ...
The Artificial Intelligence (AI) chip market has been growing rapidly, driven by increased demand for processors that can ...
Nvidia GeForce Now Priority membership is now ‘Performance’ Price will remain the same, with 1440p resolution and ultrawide support additions The playtime limit will come into effect on ...
Semiconductor-sector investors will be paying close attention this week as the major cloud-computing companies report their quarterly results.
Nvidia shares hit a record high on Monday, closing at $138.07 as Wall Street anticipates earnings updates from Microsoft, Meta, Google, and Amazon on their AI infrastructure spending. The stock ...
One stock to keep an eye on is Novartis (NVS). NVS is currently sporting a Zacks Rank of #2 (Buy), as well as a Value grade of A. The stock has a Forward P/E ratio of 13.33. This compares to its ...
*The upcoming earnings date is derived from an algorithm based on a company's historical reporting dates. It is possible that this date will be updated in the future, once the company announces ...
Just one day separated Nvidia nearly stealing Apple’s crown as the most valuable company in the world and the company shedding roughly $149 billion in market value. A swing like that is enough ...
Shares of Nvidia increased by more than 2% Monday, ending the chip maker’s day at a record close as the company is once again on the cusp of becoming the world’s most-valuable company ahead of ...
Positive Outlook For Novartis As Company Capitalizes On Growing Treatment Opportunities, Analyst Highlights Novartis aims to enhance Pluvicto's market presence while exploring growth in multiple ...